Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous platelet-rich plasma (Yantai Yuhuangding Hospital)
- Development stage
- Unknown
- Lead developer
- Yantai Yuhuangding Hospital
- Modality
- Cell Therapies
- Administration
- Intraarticular
01
Overview
Autologous platelet-rich plasma (PRP) is a concentrated preparation of platelets derived from a patient's own blood, containing a high density of growth factors and cytokines. These include platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF), which are released upon platelet activation. In the clinical trial conducted by Yantai Yuhuangding Hospital, PRP is administered via intra-articular injection for the treatment of severe knee osteoarthritis. The therapy aims to modulate the intra-articular inflammatory environment, promote tissue repair, and alleviate pain by stimulating cellular proliferation and angiogenesis. In this specific study context, it is evaluated both as a standalone treatment and as a scaffold for autologous adipose-derived mesenchymal stem cells (AMSCs).
- Other names
- PRPautologous PRP
Beyond the preview
Go deeper on autologous platelet-rich plasma (Yantai Yuhuangding Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous platelet-rich plasma (Yantai Yuhuangding Hospital).